The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand · Delayed Price · Currency is THB 26.50
-1.00 (-3.64%)
May 29, 2026, 4:39 PM ICT
BKK:KLINIQ Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 400.03 | 363.7 | 322.19 | 288.62 | 205.49 | 129.26 |
Depreciation & Amortization | 344.45 | 333.12 | 282.3 | 194.61 | 142 | 81.19 |
Loss (Gain) From Sale of Assets | 11.15 | 5.98 | 5.17 | -0.03 | 0.44 | 2.29 |
Asset Writedown & Restructuring Costs | - | - | - | -0 | -0.03 | - |
Other Operating Activities | -370.46 | -353.12 | -463.93 | -342.62 | -216.48 | -194.24 |
Change in Accounts Receivable | -0.41 | -5.42 | 5.08 | -9.56 | -1.41 | -0.59 |
Change in Inventory | -71.31 | -115.96 | -82.63 | -70.99 | -35.51 | 18.53 |
Change in Accounts Payable | 30 | 81.33 | 34.53 | 52.64 | 37.18 | 26.35 |
Change in Unearned Revenue | 463.2 | 414.38 | 451.73 | 326.59 | 334.25 | 183.82 |
Change in Other Net Operating Assets | -66.42 | -63.24 | -2.46 | -53.33 | -57.98 | -8.03 |
Operating Cash Flow | 740.15 | 660.77 | 551.98 | 385.92 | 407.96 | 238.56 |
Operating Cash Flow Growth | 12.55% | 19.71% | 43.03% | -5.40% | 71.01% | -3.91% |
Capital Expenditures | -299.25 | -300.15 | -571.67 | -366.52 | -225.79 | -72.92 |
Sale of Property, Plant & Equipment | 18.18 | 20.78 | 39.34 | 0.58 | - | 2.6 |
Sale (Purchase) of Intangibles | -0.93 | -0.7 | -1.13 | -0.59 | -1.16 | -1.12 |
Investment in Securities | -67.05 | 128.03 | 529.37 | -60.1 | -1,000 | - |
Other Investing Activities | -4.18 | -5.58 | 19.89 | 5.26 | 0.52 | 20.06 |
Investing Cash Flow | -353.23 | -157.61 | 15.79 | -421.37 | -1,226 | -51.37 |
Short-Term Debt Repaid | - | - | - | - | - | -12.94 |
Long-Term Debt Repaid | - | -137.36 | -120.39 | -89.51 | -63.39 | -27.63 |
Total Debt Repaid | -147.1 | -137.36 | -120.39 | -89.51 | -63.39 | -40.57 |
Net Debt Issued (Repaid) | -147.1 | -137.36 | -120.39 | -89.51 | -63.39 | -40.57 |
Issuance of Common Stock | 20 | 20 | - | - | 1,470 | - |
Common Dividends Paid | -319 | -319 | -308 | -231 | -153.2 | -80 |
Other Financing Activities | -20 | - | - | - | -46.4 | - |
Financing Cash Flow | -466.1 | -436.36 | -428.39 | -320.51 | 1,207 | -120.57 |
Net Cash Flow | -79.18 | 66.8 | 139.38 | -355.96 | 388.54 | 66.62 |
Free Cash Flow | 440.9 | 360.62 | -19.7 | 19.39 | 182.17 | 165.64 |
Free Cash Flow Growth | 122.77% | - | - | -89.35% | 9.97% | 65.76% |
Free Cash Flow Margin | 11.52% | 10.14% | -0.66% | 0.85% | 11.11% | 17.44% |
Free Cash Flow Per Share | 2.00 | 1.64 | -0.09 | 0.09 | 1.07 | 1.03 |
Cash Interest Paid | 26.95 | 26.34 | 23.9 | 15.1 | 10.66 | 4.32 |
Cash Income Tax Paid | 84.23 | 84.27 | 64.42 | 55.28 | 35.39 | 22.17 |
Levered Free Cash Flow | 404.46 | 295.05 | -51.44 | -20.98 | 175.4 | 167.45 |
Unlevered Free Cash Flow | 421.32 | 311.51 | -36.5 | -11.54 | 182.06 | 170.15 |
Change in Working Capital | 355.06 | 311.08 | 406.25 | 245.35 | 276.53 | 220.06 |